FDA Adverse Event Malfunction Summary report: N

ALINITY C PROCESSING MODULE

MDR report key: 21650710 · Received March 20, 2025

Report

Report Number
3016438761-2025-00176
Event Type
Malfunction
Date Received
March 20, 2025
Date of Event
March 3, 2025
Report Date
March 26, 2025
Manufacturer
ABBOTT LABORATORIES
Product Code
JJE
UDI-DI
00380740137380
PMA / PMN Number
K170316
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ABBOTT FIELD SERVICE (FS) INVESTIGATED THE ISSUE ON SITE. FS TROUBLESHOOTING INCLUDED REPLACING THE ICT PRE AMP CABLE WHICH RESOLVED THE ISSUE. THERE HAVE BEEN NO FURTHER REPORTS OF DISCREPANT RESULTS SINCE THE PART WAS REPLACED. A REVIEW OF THE ALINITY C PROCESSING MODULE SN# (B)(6) SERVICE HISTORY WAS NOT ABLE TO IDENTIFY OR CONFIRM ANY ADDITIONAL LIKELY CAUSES. A REVIEW OF HISTORICAL DATA REVEALED NO TRENDS, SYSTEMIC ISSUES, OR RELATED NONCONFORMANCES. A REVIEW OF THE CLINICAL CHEMISTRY SYSTEMS REVEALED FOUND NO SYSTEMIC ISSUES OR TRENDS FOR THE ISSUE ASSOCIATED WITH THIS TICKET (ERRATIC/DISCREPANT RESULTS). A REVIEW OF LABELLING ADEQUATELY ADDRESSES SAMPLE RESULTS OBSERVED PROBLEMS FOR ERRATIC / DISCREPANT RESULTS. BASED ON THE INVESTIGATION NO SYSTEMIC ISSUE OR PRODUCT DEFICIENCY WAS IDENTIFIED FOR THE ALINITY C PROCESSING MODULE SN# (B)(6).

Additional Manufacturer Narrative · 0

AN EVALUATION IS IN PROCESS. A FOLLOW UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE.

Description of Event or Problem · 0

THE CUSTOMER REPORTED FALSELY ELEVATED SODIUM RESULTS GENERATED ON THE ALINITY C PROCESSING MODULE ON TWO PATIENTS. RESULTS PROVIDED: PATIENT 1 = 175/ 136 MMOL/L, PATIENT 2 = 200 / 140 MMOL/L , NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED FALSELY ELEVATED SODIUM RESULTS GENERATED ON THE ALINITY C PROCESSING MODULE ON TWO PATIENTS. RESULTS PROVIDED: PATIENT 1 = 175/ 136 MMOL/L. PATIENT 2 = 200 / 140 MMOL/L. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1372833 ALINITY C PROCESSING MODULE ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE JJE ABBOTT LABORATORIES 00380740137380

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown ALNTY C ICT SAMPLE DILU, 07P53-20, (B)(6)| ALNTY C ICT SAMPLE DILU, 07P53-20, (B)(6)